Welgus Howard G. Sells 10,000 Shares of Arcutis Biotherapeutics, Inc. Common Stock

Howard G. Welgus, a director at Arcutis Biotherapeutics, Inc., sold 10,000 shares of common stock on April 1, 2026, pursuant to a 10b5-1 trading plan. The weighted average sale price was $23.88 per share, with individual sales ranging from $23.61 to $24.12. Following this transaction, Welgus owns 39,744 shares of the company's common stock. This transaction is part of a trading plan that ends on May 29, 2026. The specific details of each transaction, including the number of shares sold at each price, will be provided to the SEC upon request.